SinomedTrip
← Back to articles
4 min read
SinomedTrip Team

Peking Union Medical College Hospital Performs First Transcatheter Valve Replacement for Severe Aortic Regurgitation

PUMCH successfully completed its first transfemoral TAVR procedure for pure severe aortic regurgitation using a next-generation valve — patient recovered in 72 hours without open-heart surgery.

Medically reviewed by SinomedTrip's clinical team

A Cardiac Milestone at China's Most Prestigious Hospital

Peking Union Medical College Hospital (PUMCH) — consistently ranked as China's #1 hospital — has successfully performed its first transfemoral transcatheter aortic valve replacement (TAVR) for a patient with pure severe aortic regurgitation, a condition historically requiring open-heart surgery.

A Cardiac Milestone at China's Most Prestigious Hospital

The Patient

A 71-year-old man, referred to as Mr. Li, presented with severe aortic valve regurgitation complicated by:

  • Chronic obstructive pulmonary disease (COPD)
  • Celiac trunk artery aneurysm
  • Hypertension

His multiple comorbidities made traditional open-heart valve replacement extremely high-risk. The surgical team determined that a minimally invasive transcatheter approach offered the best risk-benefit ratio.

The Procedure

The PUMCH structural heart disease intervention team performed the TAVR through the femoral artery (groin access) under non-intubated anesthesia — meaning Mr. Li breathed on his own throughout the procedure without a breathing tube.

Key technical details:

  • No chest incision — The entire procedure was performed through a small puncture in the groin
  • Next-generation valve — A specialized prosthetic valve designed specifically for aortic regurgitation (not stenosis), representing a new class of devices
  • Real-time imaging guidance — Transesophageal echocardiography and fluoroscopy guided precise valve positioning

The Procedure

The Results

MetricOutcome
Aortic regurgitation post-procedureEliminated
Time to walking24 hours
Hospital discharge72 hours (3 days)
Left ventricular sizeSignificantly reduced by Day 1
Left ventricular functionImproved

The PUMCH cardiac team reported that their overall TAVR program has achieved 100% survival rates at perioperative, 1-year, and 2-year follow-up — an exceptional benchmark.

Why This Matters

Traditional treatment for severe aortic regurgitation requires open-heart surgery with:

  • A 15-25 cm chest incision (sternotomy)
  • Cardiopulmonary bypass (heart-lung machine)
  • 7-14 days of hospitalization
  • 6-12 weeks of recovery
  • Significant risk for elderly patients with comorbidities

The TAVR approach eliminates all of this. The patient goes home in 3 days and returns to normal activity within 1-2 weeks.

TAVR Cost Comparison

ItemChina (PUMCH)United StatesUnited Kingdom (Private)
TAVR procedure (total)$25,000 - $45,000$150,000 - $300,000$60,000 - $120,000
Hospital stay (3-5 days)Included$15,000 - $30,000/day$5,000 - $10,000/day
Follow-up echo + consultationIncluded$2,000 - $5,000$1,000 - $3,000

About Peking Union Medical College Hospital

Founded in 1921 by the Rockefeller Foundation, PUMCH is China's most respected medical institution:

  • Ranked #1 in China for 14 consecutive years
  • JCI accredited with international patient services
  • Houses over 60 clinical departments with world-class specialists
  • Located in central Beijing, easily accessible for international patients

How to Access TAVR at PUMCH

Through SinomedTrip, international patients can access PUMCH's cardiac program:

  1. Submit your echocardiogram and cardiac imaging for remote review by the structural heart team
  2. Receive a candidacy assessment within 48 hours
  3. Travel to Beijing — we arrange airport pickup, hotel near the hospital, and medical interpreter
  4. Procedure and recovery — typically 5-7 days total in China for TAVR patients

Frequently Asked Questions

What is TAVR and how is it different from open-heart valve replacement?

Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive procedure where a new heart valve is delivered through a catheter inserted in the leg artery and deployed inside the diseased valve. Unlike open-heart surgery, it does not require stopping the heart, using a heart-lung machine, or cutting through the breastbone. This means shorter recovery, less pain, and lower risk for patients who are elderly or have other health conditions.

Why is TAVR for aortic regurgitation considered more challenging than TAVR for aortic stenosis?

In aortic stenosis, the diseased valve has calcium buildup that provides an anchor point for the new valve. In aortic regurgitation, the valve leaflets are floppy and there is often no calcium to grip, making it much harder to secure the replacement valve in position. PUMCH's achievement of performing this procedure successfully represents a significant technical advance that expands TAVR to a new patient population.

Am I a candidate for TAVR instead of open-heart surgery?

TAVR is typically recommended for patients who are at intermediate to high surgical risk for open-heart surgery due to age, frailty, or other medical conditions. The PUMCH cardiac team evaluates candidacy through detailed imaging (CT angiography of the heart and blood vessels), echocardiography, and overall health assessment. SinomedTrip can arrange a remote evaluation to determine if TAVR is appropriate for your condition.

How much does TAVR cost in China compared to the United States?

TAVR at PUMCH costs approximately $30,000 to $50,000 including the valve device, procedure, and hospital stay, compared to $80,000 to $170,000 in the United States. For patients who are paying out of pocket or whose insurance does not cover TAVR, the cost savings in China can be substantial while accessing the same quality of care and device technology.

What is the recovery process after TAVR and how soon can I return home?

Most TAVR patients are walking within 24 hours of the procedure and discharged from the hospital within 3 to 5 days. A follow-up echocardiogram is performed before discharge to confirm the valve is functioning properly. Most patients can fly home 1 to 2 weeks after the procedure, once cleared by the cardiology team. Full recovery and return to normal activities typically takes 2 to 4 weeks.


Have a heart valve condition? Request a free assessment from PUMCH's cardiac team →

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.

Related Articles

Modified Device, Maximized Safety: Tangdu Hospital's Improved Endovascular Approach to Thoracic Aortic Disease

Tangdu Hospital's vascular surgery team used a modified endovascular delivery system to repair complex thoracic aortic disease — breaking through anatomical barriers that would have required open chest surgery at most hospitals.

Read More

Two Ticking Time Bombs, One Surgery: PUMCH Implants Artificial Heart While Sealing Brain Aneurysm

PUMCH completed a landmark combined procedure — implanting a left ventricular assist device (artificial heart) while simultaneously embolizing a cerebral aneurysm — defusing two life-threatening conditions in a single operation.

Read More

50 Days, 7 Departments, 2 Surgeries: How PUMCH Saved a Man from a Condition That Kills 85% of Patients

A 35-year-old man developed a life-threatening aortoesophageal fistula after aortic dissection surgery. PUMCH's 7-department team performed two staged operations over 50 days to rebuild his aorta and esophagus — defying a condition with 85%+ mortality.

Read More

China's First MVIV + BATMAN: West China Hospital's Dual Innovation Saves 72-Year-Old from Open-Heart Redo

West China Hospital performed China's first combined transcatheter mitral valve-in-valve replacement with balloon-assisted leaflet displacement — solving a problem that would have required risky repeat open-heart surgery.

Read More